Series 161: Research Liaison Duties

Series 161 Research Liaison Duties questions help you isolate one part of the FINRA outline before returning to a mixed practice test. The questions below are original Securities Prep practice items aligned to this topic and are not copied from any exam sponsor.

Topic snapshot

Sample questions

Question 1

A supervisory analyst is reviewing a company research report before publication. The issuer was sent a draft only to verify factual statements, and it replied by correcting the CFO’s start date and a product launch date, asking that “margin deterioration” be changed to “temporary margin pressure,” and requesting removal of the underperform rating. The report has not yet been approved or disseminated. What is the best supervisory action?

• A. Accept all requested edits if the analyst maintains Reg AC certification.
• B. Hold publication until the issuer approves the full draft.
• C. Accept factual corrections only, reject tone and rating requests, document issuer review, and continue independent approval.
• D. Reject every issuer comment because draft review is impermissible.

Best answer: C

Explanation: Issuer factual verification may be used to correct objective errors, but the issuer must not shape the report’s tone, conclusions, or recommendation.

Issuer review may be used for factual checking, but it cannot be allowed to influence the research opinion, recommendation, or tone. The supervisory analyst should separate objective corrections from improper editorial pressure, document the limited issuer review, and keep approval independent.

The key boundary is between factual verification and issuer influence. A firm may let an issuer identify objective errors, such as an executive’s start date or a product launch date, because those are factual matters. But requests to soften negative language or remove an underperform rating go directly to tone, conclusion, and recommendation, which must remain the firm’s independent research judgment.

The supervisory analyst should:

• accept verifiable factual corrections
• reject changes aimed at tone or recommendation
• document the scope of the issuer review and the firm’s handling of comments
• continue the normal independent approval process before dissemination

The closest mistake is rejecting all issuer comments, but factual corrections are allowed when kept within proper boundaries.

• Reg AC confusion fails because analyst certification does not permit the issuer to influence wording or recommendations.
• Issuer signoff fails because research publication does not depend on issuer approval of the full draft.
• Reject all comments fails because limited factual verification by the issuer is permissible and often useful.

Question 2

A supervisory analyst is reviewing a pending rating-change report. The issuer is not on the firm’s restricted list, the analyst’s Reg AC certification is on file, and the report’s disclosures are complete. Firm policy permits research personnel and related accounts to trade covered issuers only if the trade is precleared and later matched to duplicate confirms or account statements. Compliance learns that the analyst’s spouse sold the issuer’s shares through an outside account three days earlier, but no preclearance approval or duplicate-account records were retained. What is the primary compliance risk?

• A. Inability to evidence that the spouse account trade was precleared and monitored
• B. Inability to show that dissemination was delayed to sales personnel
• C. Inability to show that the analyst signed the required certification
• D. Inability to show that the issuer reviewed the draft before release

Best answer: A

Explanation: Without retained preclearance records and duplicate confirms or statements for the related account, the firm cannot demonstrate compliance with research-personnel personal-trading restrictions.

The key red flag is missing evidence that the related-account trade complied with the firm’s personal-trading controls. When a firm requires preclearance and post-trade monitoring for research personnel and related accounts, it must retain records showing those steps occurred.

This item turns on supervisory evidence of compliance with personal-account trading restrictions for research personnel. The stem says the firm allows trades only if they are precleared and then matched to duplicate confirms or account statements. Because the spouse’s outside-account trade occurred and the firm retained neither the preclearance approval nor the follow-up account records, the firm cannot prove that the trade was reviewed, permitted, and monitored under its policy.

Those records matter because research-personnel restrictions typically extend to related accounts, not just the analyst’s own account. An annual attestation or general policy is not enough when a specific trade must be reconstructed and tested against firm restrictions. The main problem is therefore books-and-records evidence of personal-trading compliance, not report content or release mechanics. The key takeaway is that missing control records are the decisive supervisory red flag.

• The issuer-review idea fails because the stem identifies no issuer-review requirement, and that is not the control used to evidence personal-account trading compliance.
• The certification idea fails because the analyst’s Reg AC certification is already stated to be on file.
• The delayed-dissemination idea fails because the stem says dissemination will be broad and simultaneous, so selective release is not the central issue.

Question 3

A supervisory analyst learns that a company research report posted to the firm’s client portal omitted a required disclosure. Distribution is stopped immediately, and research may either issue a corrected report later today or withdraw the report entirely. Before deciding whether the firm needs only an internal hold notice, a replacement notice, or an affirmative withdrawal communication to prior recipients, what must the supervisory analyst confirm first?

• A. Whether prior recipients accessed the withdrawn version before the stop-release
• B. Whether operations can overwrite the portal file immediately
• C. Whether the analyst has refreshed the rating support memo
• D. Whether legal has precleared wording for a corrective message

Best answer: A

Explanation: Notice obligations turn first on whether the defective report actually reached prior recipients before distribution was halted.

The first issue is dissemination status. If the flawed report never reached prior recipients, an internal hold may be enough; if it did, the firm must decide between a replacement notice and an affirmative withdrawal communication based on whether a corrected report will follow.

For a withdrawn research report, the supervisory analyst should first confirm whether the report was actually disseminated to prior recipients before the halt took effect. That fact determines whether the problem is only a forward-looking stop on further use or a corrective communication issue for people who already received the report.

A practical sequence is:

• Confirm whether any customers or other prior recipients could access the flawed version.
• If no one received it, an internal hold notice may be sufficient.
• If recipients already received it and a corrected report will follow, a replacement notice is appropriate.
• If recipients already received it and no replacement will follow, an affirmative withdrawal communication is needed.

Steps such as drafting notice language, revising support, or removing the portal copy matter, but they come after the dissemination fact is known.

• The option about legal wording is secondary because the firm must first know whether any recipient communication is required at all.
• The option about refreshing rating support addresses report substance, not the immediate correction-and-notice path.
• The option about overwriting the portal file helps stop future access, but it does not establish whether prior recipients already received the report.

Question 4

A supervisory analyst is reviewing a draft rating-change notice before dissemination. Firm policy permits investment banking to review research only for factual accuracy and prohibits investment banking from influencing a rating, price target, or publication timing.

Exhibit: Internal email excerpt

From: Investment Banking VP
To: Research Analyst
Subject: Issuer update

Please hold the downgrade until after tomorrow's pitch.
Also move the price target back to $42 so we do not
complicate the financing discussion.

Reply from Research Analyst:
Understood. I will revise and recirculate.

Before approving the notice, what is the most appropriate supervisory analyst action?

• A. Send the draft to the issuer for factual review before publication
• B. Allow dissemination but add the issuer to the watch list afterward
• C. Escalate the matter and block dissemination pending compliance review
• D. Approve the notice if the disclosure states the firm may seek banking business

Best answer: C

Explanation: The exhibit shows investment banking attempting to influence the rating change’s timing and price target, creating an independence concern that requires escalation before dissemination.

The email shows more than permitted factual checking. Investment banking is trying to affect both the substance of the research and when it is published, so the supervisory analyst should stop dissemination and escalate the conflict concern.

The core issue is research independence. Under the stated policy, investment banking may not influence a research communication’s rating, price target, or timing. The exhibit explicitly asks the analyst to delay the downgrade until after a pitch and to change the price target to avoid harming a financing discussion. That is a direct attempt to shape research for banking purposes, not a factual correction.

A supervisory analyst should treat that as an independence and conflict concern and escalate it to compliance or legal under firm procedures before approving dissemination. Publication should not proceed while the tainted draft remains unresolved. A disclosure that the firm may seek banking business does not cure improper banking influence over content or timing.

The key takeaway is that banking input on factual accuracy can be permitted, but banking pressure on recommendation content or release timing requires restriction or escalation.

• Disclosure cure fails because a general banking disclosure does not fix improper investment banking influence over content or timing.
• Issuer fact check misses the issue because the conflict arises from investment banking pressure, not from missing issuer factual verification.
• Watch list later is insufficient because the problem must be escalated before dissemination, not addressed only after release.

Question 5

A supervisory analyst is asked to approve a company update on Delta Health. Before approval, an investment banking vice president emails the research analyst: “We are pitching Delta for a debt offering next week, so soften the discussion of leverage and litigation risk.” Under these facts, which response is NOT appropriate?

• A. Permit softer risk language to avoid harming the pitch
• B. Preserve the email and notify research management
• C. Escalate the contact to compliance and pause approval
• D. Consult compliance about a watch-list or dissemination restriction

Best answer: A

Explanation: Banking cannot influence research content for deal purposes, so accommodating the request would compromise research independence and requires escalation instead.

This investment banking email is a clear attempt to influence research content for business reasons. The supervisory analyst should escalate, document, and review possible restrictions before approval proceeds, not let banking shape the report.

The core issue is research independence. When investment banking asks an analyst to soften negative analysis because the firm is pursuing business with the issuer, that contact creates a conflict concern requiring escalation and supervisory review. A supervisory analyst should stop the approval process long enough to involve compliance or research management, preserve the communication, and determine whether a watch-list, restricted-list, or other dissemination control is needed.

Even if revised language might look supportable on its face, research cannot be edited to serve a banking pitch. The published report must reflect the analyst’s independent views and a proper supervisory process, not business pressure from investment banking. The key takeaway is that business-motivated input from banking is an independence problem to manage, not a drafting suggestion to accommodate.

• Escalating the contact and pausing approval is appropriate because the conflict must be reviewed before dissemination.
• Preserving the email and notifying research management is appropriate because the attempted influence should be documented and supervised.
• Consulting compliance about a watch-list or dissemination restriction is appropriate when banking activity may require added controls.
• Allowing softer risk language fails because the requested change is tied to winning business, not to independent research judgment.

Question 6

A supervisory analyst reviews a correction package for a company research note distributed yesterday. The revised note fixes a material factual error in a valuation table, but the rating and price target are unchanged. The file includes updated disclosures, analyst recertification, approval signatures, and a plan to send the revised note to the original recipients and vendors. Which missing control is the key deficiency before dissemination can proceed?

• A. Expanded generic risk disclosure in the revised note
• B. A superseding distribution record withdrawing the earlier note from further use
• C. A sales-desk summary of the unchanged rating and target
• D. An issuer fact-check acknowledgment for the corrected table

Best answer: B

Explanation: The main supervisory gap is a documented control showing the revised note expressly supersedes the prior note and that the earlier version will not continue to circulate.

When research already in the market is materially corrected, the supervisory issue is not just approving the revised text. The firm must also control redistribution so the inaccurate version is replaced or blocked, with a record showing the new note supersedes the old one.

This tests corrections, updates, and redistribution controls. A revised research note that fixes a material factual error should not simply be sent out as another version with no linkage to the original. Before approving dissemination, the supervisory analyst should verify that the firm has a documented process showing the revised note explicitly supersedes the earlier communication and that internal and external channels will stop using, forwarding, or redistributing the prior version.

• The revised note should be tied to the original distribution.
• Vendors and recipients should receive replacement or withdrawal instructions.
• Retained records should show how the older version was flagged, replaced, or removed from further use.

Updated disclosures and approval signatures matter, but they do not solve the core risk of stale or inaccurate research continuing to circulate.

• Issuer check can help factual accuracy, but it does not address whether the prior distributed note remains available for redistribution.
• More risk boilerplate may improve completeness, but the stem turns on version-control documentation, not a disclosure gap.
• Sales summary may help internal coordination, but it does not replace a documented superseding and withdrawal process.

Question 7

Before a research analyst’s live television interview about a covered issuer, which disclosure is most clearly an event-specific conflict that should be refreshed immediately before the appearance rather than handled only through standing boilerplate language?

• A. The firm’s generic description of price-target methodology
• B. The standard explanation that opinions may change without notice
• C. The firm’s general rating-system definitions
• D. Whether the analyst or household has a financial interest in the issuer

Best answer: D

Explanation: Current personal or household ownership is a fact-specific conflict that can change and therefore should be reverified before the public appearance.

Event-specific public-appearance disclosures are tied to current conflict facts, not static explanatory language. A research analyst’s or household member’s financial interest can change over time, so it must be checked and updated before the appearance.

The key distinction is between stable background language and current conflict information. Standing disclosure language includes items such as rating definitions, methodology descriptions, and other standard explanatory text that can usually be maintained in approved form. By contrast, event-specific conflict disclosure depends on facts that may have changed by the time of the public appearance. In this scenario, whether the analyst or a household member has a financial interest in the issuer is a current conflict fact, so it should be refreshed before the interview.

The main takeaway is that public-appearance controls should reverify live conflict facts, not just rely on canned disclosure language.

• Rating definitions are standing explanatory language, not a changing conflict tied to that appearance.
• Opinions may change is generic cautionary wording, not issuer-specific conflict disclosure.
• Methodology description explains how price targets are set, but it does not refresh a current conflict fact.

Question 8

A supervisory analyst reviews two live webcast appearances by a research analyst. In Appearance 1, the analyst gives broad market commentary until an audience member asks about Orion Devices; the analyst answers, “We still rate Orion Buy, and our $48 price target is unchanged.” In Appearance 2, after similar market commentary, the analyst answers a question about Orion by saying only, “Please see our latest published report; I am not adding to it here.” Which treatment best matches FINRA public-appearance obligations?

• A. Neither appearance requires additional disclosure because spontaneous audience questions are exempt from public-appearance rules.
• B. Appearance 1 requires issuer-specific public-appearance disclosures and retention of the Q&A record; Appearance 2 adds no new issuer-specific disclosure beyond normal appearance recordkeeping.
• C. Appearance 2 requires follow-up disclosure because it referenced a research report, while Appearance 1 does not because the rating was unchanged.
• D. Both appearances require the same issuer-specific disclosures because Orion was mentioned in each response.

Best answer: B

Explanation: An unscripted issuer-specific rating and price-target comment is still a public appearance recommendation, so the related disclosures and recordkeeping apply to that Q&A.

Spontaneous Q&A does not remove public-appearance obligations. When the analyst gives an issuer-specific view, such as reaffirming a rating or price target, the public-appearance disclosure framework applies and the firm should preserve the Q&A as part of its records.

The key distinction is whether the analyst’s spontaneous response becomes an issuer-specific recommendation or investment opinion. In Appearance 1, the analyst did more than identify coverage; she reaffirmed a rating and price target, so the answer is part of the public appearance and carries the related issuer-specific disclosure obligations. The firm should also retain a record of that appearance, including the Q&A.

In Appearance 2, the analyst did not add a substantive view; she only directed the audience to existing published research. That does not create a new issuer-specific disclosure event from the Q&A itself, although the firm still keeps the usual record of the public appearance. The closest trap is treating spontaneity or an unchanged rating as an exception, but neither removes the disclosure framework once the analyst gives a substantive issuer view.

• Spontaneous is not exempt because unscripted Q&A can still be part of a regulated public appearance.
• Issuer mention alone is not enough; simply pointing listeners to an existing report is different from giving a live substantive view.
• Unchanged rating still counts because reaffirming a rating or price target is still an issuer-specific recommendation for disclosure purposes.

Question 9

A supervisory analyst is reviewing a planned television interview. A research analyst will discuss a covered issuer, restate the firm’s current buy rating, and answer questions about near-term catalysts. The analyst’s spouse owns shares of the issuer. The firm has no investment banking relationship with the issuer, does not make a market in the stock, and neither the firm nor its affiliates beneficially own 1% or more of the issuer’s common equity. Which statement is most accurate?

• A. The appearance must include the same full disclosure package required for a written research report.
• B. The appearance should disclose the analyst household’s financial interest in the issuer.
• C. No disclosure is required because the household holding is below 1% of the issuer’s shares.
• D. Only firm-level conflicts must be disclosed during a public appearance, not household holdings.

Best answer: B

Explanation: A spouse’s holding is a household financial interest, so that conflict should be disclosed during the analyst’s public appearance.

A television interview is a research analyst public appearance, and the analyst’s spouse’s ownership creates a household financial interest. That interest should be disclosed even though the firm has no stated investment banking, market-making, or 1%-ownership conflict.

The key concept is that public-appearance disclosure focuses on material analyst and firm conflicts that are actually present under the facts. Here, the fact that matters is the spouse’s stock ownership, which is a household financial interest in the subject issuer. Because the analyst is publicly discussing that issuer and restating the firm’s rating, the appearance should disclose that household interest.

The other listed firm conflicts are absent, so they do not create additional required disclosures on these facts. Also, public appearances do not simply import every disclosure item that might appear in a written research report. The supervisory analyst’s job is to verify that the applicable conflict disclosure is made for the appearance that is actually being given.

The main trap is confusing a 1%-ownership threshold with the separate requirement to disclose an analyst or household financial interest.

• 1% confusion fails because household financial interest disclosure is not limited to cases where the household owns 1% or more.
• Firm-only view fails because analyst and household conflicts can require disclosure in a public appearance.
• Report-style overreach fails because a public appearance is not required to carry every disclosure used in a written research report.

Question 10

A research analyst appears on a live industry webcast. Compliance approved the slides before the event, but the firm does not have a full transcript or recording. The supervisory analyst confirms the analyst orally disclosed the firm’s market-making activity and a recent investment banking relationship during the appearance. Before the event file is closed, what is the best next step?

• A. Ask legal to approve a written script after the webcast and file that instead
• B. Wait until the next research report to capture the same conflicts in writing
• C. Retain the approved slides and pre-event clearance emails as sufficient evidence
• D. Retain a dated contemporaneous record of the disclosures actually made, tied to the event and analyst

Best answer: D

Explanation: A contemporaneous record of the actual oral disclosures best evidences compliance when no transcript or recording exists.

The key is to retain evidence of what was actually disclosed during the public appearance, not just what was planned in advance. If there is no transcript or recording, the best post-event documentation is a dated contemporaneous memo, checklist, or attestation linked to the event and the analyst.

For a public appearance, the supervisory control issue is post-event evidence of the disclosures actually made. Pre-event slide approval helps show that the firm reviewed planned content, but it does not prove the analyst gave the required oral disclosures during the live event. When no transcript or recording is available, the firm should create and retain a contemporaneous written record identifying the event, the analyst, and the specific disclosures made.

A strong retained record typically includes:

• the event name and date
• the analyst’s identity
• the disclosures actually stated during the appearance
• the person preparing or confirming the record

That approach supports supervisory review and later regulatory inspection. A retroactive script or a later research report may mention the same conflicts, but neither is the best evidence of what was disclosed at the event itself.

• Planned vs. actual retaining slides and clearance emails shows advance review, not the oral disclosures actually delivered.
• Retroactive script a script approved after the webcast does not reliably evidence what was said live.
• Too late waiting for the next research report delays the record and does not document the public appearance itself.

Continue with full practice

Use the Series 161 Practice Test page for the full Securities Prep route, mixed-topic practice, timed mock exams, explanations, and web/mobile app access.

Related focused pages

• Research Communications Review
• Free Series 161 Full-Length Practice Exam

Free review resource

Use the Series 161 Cheat Sheet on SecuritiesMastery.com when you want a compact review before returning to the FINRA Series 161 Practice Test page.